These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
215 related articles for article (PubMed ID: 8319212)
21. Antitumor activity of delta 7-prostaglandin A1 and delta 12-prostaglandin J2 in vitro and in vivo. Kato T; Fukushima M; Kurozumi S; Noyori R Cancer Res; 1986 Jul; 46(7):3538-42. PubMed ID: 3708585 [TBL] [Abstract][Full Text] [Related]
22. [Pharmacodynamic tests of wulong kangai on transplantable tumors in mice]. Liu YQ; Li CH; Yang GL; Chen H Zhongguo Zhong Yao Za Zhi; 2005 Nov; 30(21):1689-91. PubMed ID: 16400950 [TBL] [Abstract][Full Text] [Related]
23. Novel phosphonium salts display in vitro and in vivo cytotoxic activity against human ovarian cancer cell lines. Manetta A; Gamboa G; Nasseri A; Podnos YD; Emma D; Dorion G; Rawlings L; Carpenter PM; Bustamante A; Patel J; Rideout D Gynecol Oncol; 1996 Feb; 60(2):203-12. PubMed ID: 8631539 [TBL] [Abstract][Full Text] [Related]
24. 1,2-Bis(methylsulfonyl)-1-(2-chloroethyl)-2-(methylamino)carbonylhydrazine (101M): a novel sulfonylhydrazine prodrug with broad-spectrum antineoplastic activity. Finch RA; Shyam K; Penketh PG; Sartorelli AC Cancer Res; 2001 Apr; 61(7):3033-8. PubMed ID: 11306484 [TBL] [Abstract][Full Text] [Related]
25. Anthrapyrazoles, a new class of intercalating agents with high-level, broad spectrum activity against murine tumors. Leopold WR; Nelson JM; Plowman J; Jackson RC Cancer Res; 1985 Nov; 45(11 Pt 1):5532-9. PubMed ID: 4053027 [TBL] [Abstract][Full Text] [Related]
26. Preclinical antitumor activity of bizelesin in mice. Carter CA; Waud WR; Li LH; DeKoning TF; McGovren JP; Plowman J Clin Cancer Res; 1996 Jul; 2(7):1143-9. PubMed ID: 9816280 [TBL] [Abstract][Full Text] [Related]
28. Identification of a novel antitumor peptide based on the screening of an Ala-library derived from the LALF(32-51) region. Vallespi MG; Fernandez JR; Torrens I; Garcia I; Garay H; Mendoza O; Granadillo M; Falcon V; Acevedo B; Ubieta R; Guillen GE; Reyes O J Pept Sci; 2010 Jan; 16(1):40-7. PubMed ID: 19908203 [TBL] [Abstract][Full Text] [Related]
29. Camptothecin delivery systems: the utility of amino acid spacers for the conjugation of camptothecin with polyethylene glycol to create prodrugs. Conover CD; Greenwald RB; Pendri A; Shum KL Anticancer Drug Des; 1999 Dec; 14(6):499-506. PubMed ID: 10834271 [TBL] [Abstract][Full Text] [Related]
30. Synthesis and antitumor evaluation of 2,5-disubstituted-indazolo[4, 3-gh]isoquinolin-6(2H)-ones (9-aza-anthrapyrazoles). Krapcho AP; Menta E; Oliva A; Di Domenico R; Fiocchi L; Maresch ME; Gallagher CE; Hacker MP; Beggiolin G; Giuliani FC; Pezzoni G; Spinelli S J Med Chem; 1998 Dec; 41(27):5429-44. PubMed ID: 9876113 [TBL] [Abstract][Full Text] [Related]
31. In vitro and in vivo antileukemic effect of novel dimers consisting of 5-fluorodeoxyuridine and arabinofuranosylcytosine. Rauko P; Novotny L; Mego M; Saiko P; Schott H; Szekeres T Neoplasma; 2007; 54(1):68-74. PubMed ID: 17203895 [TBL] [Abstract][Full Text] [Related]
32. 4-Demethoxy-3'-deamino-3'-aziridinyl-4'-methylsulphonyl-daunorubicin (PNU-159548), a novel anticancer agent active against tumor cell lines with different resistance mechanisms. Marchini S; Damia G; Broggini M; Pennella G; Ripamonti M; Marsiglio A; Geroni C Cancer Res; 2001 Mar; 61(5):1991-5. PubMed ID: 11280757 [TBL] [Abstract][Full Text] [Related]
33. Comparative study of sister chromatid exchange induction and antitumor effects by homo-aza-steroidal esters of [p-[bis(2-chloroethyl)amino]phenyl]butyric acid. Camoutsis C; Catsoulacos D; Karayiann V; Papageorgiou A; Mourelatos D; Mioglou E; Kritsi Z; Nikolaropoulos S Cancer Detect Prev; 2001; 25(6):558-64. PubMed ID: 12132876 [TBL] [Abstract][Full Text] [Related]
34. Antitumor activity of the antimicrobial peptide magainin II against bladder cancer cell lines. Lehmann J; Retz M; Sidhu SS; Suttmann H; Sell M; Paulsen F; Harder J; Unteregger G; Stöckle M Eur Urol; 2006 Jul; 50(1):141-7. PubMed ID: 16476519 [TBL] [Abstract][Full Text] [Related]
35. 4-methyl-5-amino-1-formylisoquinoline thiosemicarbazone, a second-generation antineoplastic agent of the alpha-(N)-heterocyclic carboxaldehyde thiosemicarbazone series. Agrawal KC; Schenkman JB; Denk H; Mooney PD; Moore EC; Wodinsky I; Sartorelli AC Cancer Res; 1977 Jun; 37(6):1692-6. PubMed ID: 870183 [TBL] [Abstract][Full Text] [Related]
36. Synthesis, cytotoxicity and antitumor activity of platinum(II) complexes of cyclopentanecarboxylic acid hydrazide. Kushev D; Gorneva G; Taxirov S; Spassovska N; Grancharov K Biol Chem; 1999 Nov; 380(11):1287-94. PubMed ID: 10614821 [TBL] [Abstract][Full Text] [Related]
37. Experimental antitumor activity of new azathioprine analogues. Hładoń B; Gutsche W; Bałoniak S; Sikorska H Arzneimittelforschung; 1989 Jan; 39(1):78-81. PubMed ID: 2719747 [TBL] [Abstract][Full Text] [Related]
38. In vitro and in vivo pharmacological characterizations of the antitumor properties of two new olivacine derivatives, S16020-2 and S30972-1. Malonne H; Farinelle S; Decaestecker C; Gordower L; Fontaine J; Chaminade F; Saucier JM; Atassi G; Kiss R Clin Cancer Res; 2000 Sep; 6(9):3774-82. PubMed ID: 10999772 [TBL] [Abstract][Full Text] [Related]
39. Activity of lytic peptides against intracellular Trypanosoma cruzi amastigotes in vitro and parasitemias in mice. Barr SC; Rose D; Jaynes JM J Parasitol; 1995 Dec; 81(6):974-8. PubMed ID: 8544074 [TBL] [Abstract][Full Text] [Related]
40. Antitumor activity of troxacitabine (Troxatyl) against anthracycline-resistant human xenografts. Gourdeau H; Genne P; Kadhim S; Bibeau L; Duchamp O; Ouellet F; deMuys JM; Bouffard DY; Attardo G Cancer Chemother Pharmacol; 2002 Dec; 50(6):490-6. PubMed ID: 12451476 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]